Beyond my paygrade/skillset21 May 2021 10:52
Morning All
This is my second biggest investment and tbh I did all my normal research - but part of me went with my heart not head,at one point had £500k gbp invested here (a bit less now but still substantial) As we all are human and have doubts in our choices I started to undertake a full interrogation of everything about GC and his background and there are definitely question marks over his financial behaviour - if this is just because he is extremely clever and knows his way around company law in differing jurisdictions and uses it to his advantage from a tax perspective,at this stage I am unsure.
It is not in my favour to put the share down or deramp - but some of the claims of success are over blown and in one case 'Inhibitex' which he claims as a big success - the lead drug proved to be a failure and Bristol Squibbs had to write down their total investment of $2.5 billion US (8 months later) if you look at their website and see what their pipeline is - it is very similar reading to TILS... Callisto was just a spin out from Synergy - and was linked to Contravir - who became Hepion Pharma (all the same old boys network involved) Regen (gone) Biovitas (Gone) - Gensignia Life Sciences Inc allegedly still the parent company of Gensignia IP (was Gensignia Ltd in effect) is a dead pool company in the US and the clinic is closed permanently (same address in San Diego as other linked cos) Gensignia Limited was formed to manage some financial shenanigans in relation to the transfer of assets from Gensignia Holdings Inc (British Virgin Isles) and was created to be placed in adminstration one year later to move all the assets to Gensignia IP.I can read a set of accounts and understand the rudimentaries of SH01/AR01 etc but the transactions are beyond me and just look dodgy - very clever use of $ or £ handwritten values with gaps between figures that leave doubts - Gensignia Limited had 6 pages of current or previous shareholders - some names are recognisable (including Veneto Seed Farms) who are building a position in OKYO Pharma - and we all know who became Exec Chair in January 2021. I have pages and pages of info and I may just be a sceptic and as I pay my taxes I dont like jiggery pokery that appears to be the case here - to be fair to GC though some big legal companies have been involved in the advices (so all maybe above board - 'within the rules' which we all know can mean anything!
Hoping all above is just my suspicious mind adding 2+2 and arriving at 5 - but the Inhibitex transaction outcome really blew me away... (Fierce Biotech 23.08.2012 - full article)
GLA
Sporty (anyone who wants further info to do their own digging DM me)
Sign In
Follow the stocks
